ArticleJTCVS techniques2025
Redo axillary artery cannulation in aortic reoperations: Technical variations and implications for optimal outcomes.
Article in JTCVS techniques, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Recannulation of the right axillary artery (Redo-AX) is a valuable yet underutilized technique in aortic reoperations. The present study sought to analyze the outcomes of 1 of the largest redo AX cannulations experiences. Methods: From February 2005 to December 2024, AX cannulation was planned for 804 aortic repairs and analyzed according to the intention-to-treat principle. Fifty patients had Redo-AX, whereas 754 patients had primary AX cannulation. Cannulation-related events included technical failure, vascular injury, additional vascular rep, and iatrogenic retrograde dissection. Results: This cohort included 196 redo sternotomies (24.4%) and 381 type A aortic dissections (47.4%). Among the 50 Redo-AX procedures, 46 patients had direct AX cannulation, and 4 patients had the side-graft technique in their initial surgery. Forty-five patients were successfully cannulated for cardiopulmonary bypass. Two patients underwent the side-graft technique with a graft extension, and direct AX cannulation was performed in 43 patients via arteriotomy (n = 40), the Seldinger technique (n = 2), and direct cannulation through an old polyethylene terephthalate graft (n = 1). The overall rate of cannulation-related events was 2.1% (17 out of 804), and the rate of cannulation site shift was 2.7% (22 out of 804). Cannulation-related events (10% vs 1.6%; Conclusions: Redo-AX is a durable approach for complex redo aortic cases. Careful preoperative evaluation and certain surgical expertise are paramount to achieving optimal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.